Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara M Karaba

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Antimicrobial Agents and Chemotherapy|September 4, 2024
Clinical outcomes and emergence of resistance of <i>Pseudomonas aeruginosa</i> infections treated with ceftolozane-tazobactam versus ceftazidime-avibactamDariusz A Hareza, Sara E Cosgrove, Robert A Bonomo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2024
Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis With Sulbactam-DurlobactamPranita D Tamma, Shanan Immel, Sara M Karaba, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2026
Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infectionsSara M Karaba, Dariusz A Hareza, Jose M Munita, et al.
Infection Control and Hospital Epidemiology|August 27, 2021
Impact of weekly asymptomatic testing for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in inpatients at an academic hospitalLeigh Smith, Sara Pau, Susan Fallon, et al.
Open Forum Infectious Diseases|January 15, 2021
Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter StudySara M Karaba, George Jones, Taylor Helsel, et al.
Open Forum Infectious Diseases|June 6, 2025
Variability in Durations of Therapy for Gram-Negative Bloodstream Infections and Factors Associated With Prolonged DurationsJesse D Sutton, Jae Hyoung Lee, Karen Howard, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|February 20, 2026
Qualitative evaluation of a statewide antibiotic stewardship quality improvement sepsis interventionSara M Karaba, Kathryn Dzintars, Priyanka J Desai, et al.
Infection Control and Hospital Epidemiology|March 2, 2022
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) exposure investigations using genomic sequencing among healthcare workers and patients in a large academic centerLeigh Smith, C Paul Morris, Morgan H Jibowu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2026
A Clinical Case of Treatment-Emergent Acinetobacter baumannii Non-Susceptibility to Sulbactam-DurlobactamSima L Sharara, Lorena Diaz, Tomefa E Asempa, et al.
Journal of Clinical Microbiology|July 11, 2025
Multicenter evaluation of blood culture contamination and blood cultures practices in US acute care hospitals: time for standardizationValeria Fabre, Yea-Jen Hsu, Karen C Carroll, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Antimicrobial Agents and Chemotherapy|September 4, 2024
Clinical outcomes and emergence of resistance of <i>Pseudomonas aeruginosa</i> infections treated with ceftolozane-tazobactam versus ceftazidime-avibactamDariusz A Hareza, Sara E Cosgrove, Robert A Bonomo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2024
Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis With Sulbactam-DurlobactamPranita D Tamma, Shanan Immel, Sara M Karaba, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2026
Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infectionsSara M Karaba, Dariusz A Hareza, Jose M Munita, et al.
Infection Control and Hospital Epidemiology|August 27, 2021
Impact of weekly asymptomatic testing for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in inpatients at an academic hospitalLeigh Smith, Sara Pau, Susan Fallon, et al.
Open Forum Infectious Diseases|January 15, 2021
Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter StudySara M Karaba, George Jones, Taylor Helsel, et al.
Open Forum Infectious Diseases|June 6, 2025
Variability in Durations of Therapy for Gram-Negative Bloodstream Infections and Factors Associated With Prolonged DurationsJesse D Sutton, Jae Hyoung Lee, Karen Howard, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|February 20, 2026
Qualitative evaluation of a statewide antibiotic stewardship quality improvement sepsis interventionSara M Karaba, Kathryn Dzintars, Priyanka J Desai, et al.
Infection Control and Hospital Epidemiology|March 2, 2022
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) exposure investigations using genomic sequencing among healthcare workers and patients in a large academic centerLeigh Smith, C Paul Morris, Morgan H Jibowu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2026
A Clinical Case of Treatment-Emergent Acinetobacter baumannii Non-Susceptibility to Sulbactam-DurlobactamSima L Sharara, Lorena Diaz, Tomefa E Asempa, et al.
Journal of Clinical Microbiology|July 11, 2025
Multicenter evaluation of blood culture contamination and blood cultures practices in US acute care hospitals: time for standardizationValeria Fabre, Yea-Jen Hsu, Karen C Carroll, et al.
Pageof 2